Implantable cardioverter-defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve®) implantation

© 2024 Wiley Periodicals LLC..

INTRODUCTION: Tricuspid regurgitation is associated with significant morbidity and mortality, and occurs at a higher rate in patients with cardiovascular implantable electronic devices. Percutaneous strategies for managing tricuspid regurgitation are evolving, including the development of bicaval valve implantation which has been successfully used in patients with pacing leads.

METHODS AND RESULTS: We present the first documented case of lead failure following TricValve® implantation, a dedicated self-expanding system for bicaval valve implantation, and the first successful lead revision procedure in this setting.

CONCLUSION: The case illustrates important considerations in undertaking percutaneous intervention in patients with cardiovascular implantable electronic devices, and their ongoing management.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

Journal of cardiovascular electrophysiology - 35(2024), 5 vom: 01. Apr., Seite 1050-1054

Sprache:

Englisch

Beteiligte Personen:

Plant, Allan [VerfasserIn]
Stewart, Fergus [VerfasserIn]
Hooks, Darren [VerfasserIn]

Links:

Volltext

Themen:

Cardiovascular implantable electronic devices
Case Reports
Implantable cardioverter defibrillator
Journal Article
Lead failure
Structural heart intervention
Tricuspid regurgitation

Anmerkungen:

Date Completed 25.04.2024

Date Revised 25.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/jce.16249

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369909682